


BEFORE THE BOARD OF MEDICAL EXAMINERS
OF THE STATE OF NEVADA

RRR SK

In the Matter of Charges and Complaint | Case No. 21-10736-1

Against: FI LE D

CHARLES PATRICK VIRDEN, M.D.,
NOV -5 2021

NEVADA STATE BOAR
8B MEDICAL EXAMI S
y:

Respondent.

COMPLAINT

The Investigative Committee! (IC) of the Nevada State Board of Medical Examiners
(Board), by and through Aaron Bart Fricke, J.D., General Counsel, and attorney for the IC, having a
reasonable basis to believe that Charles Patrick Virden, M.D., (Respondent) violated the provisions
of Nevada Revised Statutes (NRS) Chapter 630 and Nevada Administrative Code (NAC) Chapter
630 (collectively, the Medical Practice Act), hereby issues its Complaint, stating the IC’s charges
and allegations as follows:

1. Respondent was at all times relevant to this Complaint a medical doctor holding an
active license to practice medicine in the State of Nevada (License No. 7420). Respondent was
originally licensed by the Board on May 18, 1995.

2. Pursuant to NRS 202.248(1)(a), except for use in the treatment of retinal
detachment, it is unlawful for a person to inject any liquid silicone substance into the human body.

3. Pursuant to NRS 202.248(2), a person who violates NRS_ 202.248(1)(a) is guilty of a
category D felony.

4. The injection of liquid silicone substances into the human body for use in treatments
other than retinal detachment, such as in cosmetic enhancement of the lips, face, ears, breasts or

other areas of the body, may cause substantial bodily injury, including serious and often irreparable

' The Investigative Committee of the Nevada State Board of Medical Examiners, at the time this formal
Complaint was authorized for filing, was composed of Board Members Victor M. Muro, M.D., Chair,
Weldon Havins, M.D., J.D., and Ms. Maggie Arias-Petrel.

inflammatory and granulomatous reactions, deformities, draining wounds, chronic infections, and
other serious problems that worsen over time and that often arise years after the injection.

5. Silikon® 1000 (Silikon) (also known ~ as __ dimethylpolysiloxane,
polydimethylsiloxane, or dimethicone) is a liquid silicone substance, sold as a highly purified long-
chain polydimethyisiloxane trimethysiloxy terminated silicone oil. It is approved by the U.S. Food
and Drug Administration (FDA) for post-operative tamponade during vitreoretinal surgery. It is not
FDA-approved for other applications to the human body.

6. Silikon is manufactured by Alcon, and sold by McKesson as a single-use vial
consisting of 8.5 mL. Pursuant to the manufacturer’s instructions and directions included on or with
the single-use vial, Silikon is indicated for use as a prolonged retinal tamponade in selected cases of
complicated retinal detachments where other interventions are not appropriate for patient
management. Silikon is not indicated for other uses.

7. ADATO® SIL-OL 5000 (Adatosil) is also a liquid silicone substance, sold as a
sterile, highly purified long chain polydimethylsiloxane. It is FDA-approved for retinal tamponade.
It is not FDA-approved for other applications to the human body.

8. Adatosil is manufactured and sold by Bausch & Lomb as a single-dose unit, in 10 ml
sterile glass syringes, capped with a stopper and housed inside sterilized peel back pouches.
Pursuant to the manufacturer’s instructions and directions included on or with the single-dose unit,
Adatosil is indicated for use as a prolonged retinal tamponade in selected cases of complicated
retinal detachments where other interventions are not appropriate for patient management. Adatosil
is not indicated for other uses.

9. NAC 630.040 defines malpractice as “the failure of a physician, in treating a patient,
to use the reasonable care, skill, or knowledge ordinarily used under similar circumstances.”

COUNT I
NRS 630.301(4) — Malpractice

10. All of the allegations contained in the above paragraphs are hereby incorporated by

reference as though fully set forth herein.




11. NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

12. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient A’s*
body for a treatment other than retinal detachment.

13. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient A for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

14. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

COUNT II
NRS 630.301(4) — Malpractice

15. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

16. | NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

17. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient B’s
body for a treatment other than retinal detachment.

18. | As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient B for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

19. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.


2 Patients A-O true identities are not disclosed herein to protect his or her privacy, but are disclosed in the
Patient Designation served upon Respondent contemporaneously, along with a copy of this Complaint.

o CO N DW


COUNT Il
NRS 630.301(4) — Malpractice

20. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

21. | NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

22. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient C’s
body for a treatment other than retinal detachment.

23. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient C for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

24. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

COUNT IV
NRS 630.301(4) — Malpractice

25. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

26. NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

27. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient D’s
body for a treatment other than retinal detachment.

28. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient D for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances

when rendering medical services to his patients.
BR WY WN



29. By reason of the foregoing, Respondent is subject to discipline by the Board as

provided in NRS 630.352.
COUNT V
NRS 630.301(4) — Malpractice

30. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

31. | NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

32. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient E’s
body for a treatment other than retinal detachment.

33. | As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient E for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

34. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

COUNT VI
NRS 630.301(4) — Malpractice

35. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

36. NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

37. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient F’s
body for a treatment other than retinal detachment.

38. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient F for a treatment other than

retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,


failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

39. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

COUNT VII
NRS 630.301(4) — Malpractice

40. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

41. | NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

42. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient G’s
body for a treatment other than retinal detachment.

43, As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient G for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

44. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

COUNT VIII
NRS 630.301(4) — Malpractice

45. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

46. NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

47. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient H’s
body for a treatment other than retinal detachment.




48. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient H for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

49, By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

50. By reason of the foregoing, Respondent is subject to discipline by the Nevada State
Board of Medical Examiners as provided in NRS 630.352.

COUNT IX
NRS 630.301(4) — Malpractice

51. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

52. | NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

53. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient I’s
body for a treatment other than retinal detachment.

54. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient I for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

55. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

COUNT X
NRS 630.301(4) — Malpractice
56. All of the allegations contained in the above paragraphs are hereby incorporated by

reference as though fully set forth herein.


57. | NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

58. | Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient J’s
body for a treatment other than retinal detachment.

59. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient J for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

60. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

COUNT XI
NRS 630.301(4) — Malpractice

61. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

62. NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

63. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient K’s
body for a treatment other than retinal detachment.

64. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient K for a treatment other thar
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions.
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

65. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.


COUNT Xil
NRS 630.301(4) — Malpractice

66. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

67. | NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

68. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient L’s
body for a treatment other than retinal detachment.

69. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient L for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

70. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

COUNT XIll
NRS 630.301(4) — Malpractice

71. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

72. | NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

73. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient M’s
body for a treatment other than retinal detachment.

74. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient M for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances

when rendering medical services to his patients.


75. By reason of the foregoing, Respondent is subject to discipline by the Board as

provided in NRS 630.352.
COUNT XIV
NRS 630.301(4) — Malpractice

76. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

77. | NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

78. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient N’s
body for a treatment other than retinal detachment.

79. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient N for a treatment other than
retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,
failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

80. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

COUNT XV
NRS 630.301(4) — Malpractice

81. All of the allegations contained in the above paragraphs are hereby incorporated by
reference as though fully set forth herein.

82. NRS 630.301(4) provides that malpractice of a physician is grounds for initiating
disciplinary action against a licensee.

83. Respondent injected a liquid silicone substance, Adatosil or Silikon, into Patient O’s
body for a treatment other than retinal detachment.

84. As demonstrated by, but not limited to, the above-outlined facts, Respondent, by
injecting a liquid silicon substance, Adatosil or Silikon, into Patient O for a treatment other than

retinal detachment, and in a manner inconsistent with the manufacturer’s instructions and directions,




failed to use the reasonable care, skill or knowledge ordinarily used under similar circumstances
when rendering medical services to his patients.

85. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

WHEREFORE, the Investigative Committee prays:

1. That the Board give Respondent notice of the charges herein against him and give
him notice that he may file an answer to the Complaint herein as set forth in
NRS 630.339(2) within twenty (20) days of service of the Complaint;

2. That the Board set a time and place for a formal hearing after holding an Early Case
Conference pursuant to NRS 630.339(3);

3. That the Board determine what sanctions to impose if it determines there has been a
violation or violations of the Medical Practice Act committed by Respondent;

4. That the Board award fees and costs for the investigation and prosecution of this case
as outlined in NRS 622.400;

5. That the Board make, issue, and serve on Respondent its findings of fact, conclusions
of law and order, in writing, that includes the sanctions imposed; and

6. That the Board take such other and further action as may be just and proper in these
premises.

DATED this = day of November, 2021.

INVESTIGATIVE COMMITTEE OF THE
NEVADA STATE BOARD OF MEDICAL EXAMINERS

AARO KE, ESQ.

General Counsel

9600 Gateway Drive

Reno, Nevada 89521

Tel: (702) 486-3813

Email: africke@medboard.nv.gov
Attorney for the Investigative Committee




VERIFICATION

STATE OF NEVADA )
COUNTY OF CLARK )

Victor M. Muro, M.D., having been duly sworn, hereby deposes and states under penalty of
perjury that he is the Chairman of the Investigative Committee of the Nevada State Board of
Medical Examiners that authorized the Complaint against the Respondent herein; that he has read
the foregoing Complaint; and that based upon information discovered in the course of the
investigation into a complaint against Respondent, he believes that the allegations and charges in the
foregoing Complaint against Respondent are true, accurate and correct.

DATED this 5 day of November, 2021.

INVESTIGATIVE COMMITTEE OF THE
NEVADA STATE BOARD OF MEDICAL EXAMINERS

By: (2M ford irs
VICTOR M. MURO, M.D.
Chairman of the Investigative Committee

OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners

9600 Gateway Drive

Reno, Nevada 89521

(775) 688-2559



CERTIFICATE OF SERVICE
I hereby certify that I am employed by the Nevada State Board of Medical Examiners and
that on the 5th day of November, 2021, I served a file-stamped copy of the foregoing
COMPLAINT, via U.S. Certified Mail to the following parties:

CHARLES PATRICK VIRDEN, M.D.

960 Caughlin Crossing N., Ste. 100

Reno, NV 89519

Certified Mail Receipt No.: 9171 9690 0935 0252 1579 31

With courtesy copy by U.S. Mail and electronic mail to:

ROGER M. O’DONNELL, ESQ.
Joey Gilbert Law

201 West Liberty Street, Ste. 210
Reno, NV 89501
Roger@joeygilbertlaw.com

DATED this £ yw" day of November, 2021.

—— : oe
MERCEDES FUENTES
Legal Assistant

Nevada State Board of Medical Examiners

